Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Valens Groworks Corp. (C:VGW)

Business Focus: Biotechnology & Medical Research

Get the company report for the most recent outlook updated daily
Log in or join to add this stock to your watchlist.

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for VGW within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Oct 15, 2019 16:43 ET
Valens Reports Record Revenue, Adjusted EBITDA and Profitability for the Third Quarter of Fiscal 2019
Q3 2019 Revenue of $16.5 million, Adjusted EBITDA of $9.8 million, and Net income of $5.9 millionĀ 
Read full article
Oct 15, 2019 16:43 ET
Valens Reports Record Revenue, Adjusted EBITDA and Profitability for the Third Quarter of Fiscal 2019
Q3 2019 Revenue of $16.5 million, Adjusted EBITDA of $9.8 million, and Net income of $5.9 millionĀ ...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
3.21
--
--
Price to Sales - TTM
14.16
9.28
11.01
Price to Book - most recent quarter
3.25
2.29
2.29
Price to Cash Flow per share - TTM
--
--
12.10
Price to Free Cash Flow per share - TTM
--
4.86
18.99
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Jun 30, 20191,735,482-405,120
Jun 15, 20192,140,602382,812
May 31, 20191,757,790-11,825
See Short Report

Business Summary

Sector:  Healthcare Industry:  Biotechnology & Medical Research

Valens Groworks Corp, formerly Genovation Capital Corp., is a Canada-based company, which operates as a biotechnology company in the Okanagan Valley of British Columbia. The Company is focused on the cannabis cultivation and research business. The Company's research and development facility is located in Kelowna, British Columbia. The Company provides activities of cultivation, production (extraction), packaging, possession, sale, transportation, delivery and research of medical cannabis.

See business summary

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).

Twitter

Search (past week) for $VGW.CA